Ranjit S. Chima, MD
Title
Instructor
Email
ranjit.chima@cchmc.org
Phone
513-636-4259
Fax
513-636-4267
Credentials
MBBS: Grant Medical College, Mumbai, India, 1996
MD: Pediatrics, University of Mumbai, Mumbai, India, 1999
Residency: Pediatrics, University of Mumbai, Mumbai, India, 1996-1999
Residency: Pediatrics, Children's Hospital of Michigan, Detroit, MI, 2001-2004
Fellowship: Critical Care Medicine, Cincinnati Childrens Hospital Medical Center, 2004-2007
Certification: Pediatrics, 2004
Awards and Honors
New Investigator Competition Finalist, 30th Annual Conference on Shock, Baltimore, Maryland, June 2007
Travel Grant Award, 30th Annual Conference on Shock, Baltimore, Maryland, June 2007
Sanford N. Cohen Award, Outstanding Pediatric Resident, Children's Hospital of Michigan, Detroit, June 2004
Norman M. Rosenberg Award, Best Outgoing Pediatric Emergency Resident, Children's Hospital of Michigan, Detroit, June 2004
Dr Maneck Phirozsha Bhagat Gold Medal, University of Mumbai, Mumbai, India, July 1999
Research
- Lung Injury/Inflammation
- Hemorrhagic Shock
Research Grants and Contracts
National Institutes of Health (T32 GM08478-14),
"Host response to trauma research training program", Cincinnati Children's Hospital Medical Center, University of Cincinnati,
July 2006 – June 2007
Research Fellow
Publications, Most Recent
Chima RS, Hake P, Mangeshkar P, Piraino G, Denenberg A, Zingarelli B. Ciglitazone ameliorates lung inflammation by inhibiting NF-κB/IKK pathway in hemorrhagic shock.Crit Care Med. (first revision).
Chima RS, Zingarelli B. Surfactant treatment of neonatal acute respiratory distress syndrome: is "fortification" the answer?Crit Care Med 2007;35(10):2442-3.
Presentations, Most Recent
Chima RS, Hake PW, Denenberg A, Piraino G, Mangeshkar P, Zingarelli B. Effect of ciglitazone on lung inflammation in hemorrhagic shock. Presented as Oral presentation. The Thirtieth Annual Conference on Shock, June 9-12, 2007, Baltimore, MD
Chima RS, Hake P, Piraino G, Mangeshkar P, Denenberg A, Wolfe V, Zingarelli B. Ciglitazone reduces NF-κB activity by inhibiting IKK in hemorrhagic shock. Presented as oral presentation. The 36th Critical Care Congress, Feburary 18-21, 2007, Orlando, FL
Chima RS, Hake PW, Zingarelli B. Ciglitazone, a peroxisome proliferator activated receptor gamma (PPAR) ligand reduces tissue leukosequestration in hemorrhagic shock. Presented as a poster. The Twenty-Ninth Annual Conference on Shock, June 3-6, 2006, Broomfield, CO
Chima RS, Hake P, Zingarelli B. Ciglitazone, a peroxisome proliferator- activated receptor gamma (PPAR) ligand, ameliorates hemorrhagic shock. Presented as a poster. The 35th Critical Care Congress, January 7-11, 2006, San Francisco, CA
Professional Organization Memberships
